C

Curaleaf Holdings Inc
CNSX:CURA

Watchlist Manager
Curaleaf Holdings Inc
CNSX:CURA
Watchlist
Price: 6.59 CAD 0.15%
Market Cap: 4.8B CAD
Have any thoughts about
Curaleaf Holdings Inc?
Write Note

Curaleaf Holdings Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Curaleaf Holdings Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Curaleaf Holdings Inc
CNSX:CURA
Total Receivables
$43.8m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Total Receivables
$2.1B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
1%
Canopy Growth Corp
TSX:WEED
Total Receivables
CA$41.9m
CAGR 3-Years
-23%
CAGR 5-Years
-17%
CAGR 10-Years
43%
Sundial Growers Inc
NASDAQ:SNDL
Total Receivables
CA$27.1m
CAGR 3-Years
19%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Total Receivables
$33.6m
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Total Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Curaleaf Holdings Inc
Glance View

Market Cap
4.8B CAD
Industry
Pharmaceuticals

Curaleaf Holdings Inc. is a prominent player in the burgeoning cannabis industry. With its roots firmly planted in Massachusetts, Curaleaf quietly grew from a regional entity into a nationwide powerhouse. The company's business model intricately intertwines cultivation, processing, and retail. Curaleaf's vertically integrated structure allows for end-to-end control of its product lifecycle, enhancing both quality assurance and profit margins. They meticulously nurture cannabis plants from seed to harvest, which are then transformed into a range of products, spanning from flower and oil concentrates to edibles and topicals. This comprehensive approach not only supports supply chain efficiency but also significantly bolsters brand consistency and customer satisfaction. Curaleaf's revenue streams flow primarily from its retail operations, where they operate an extensive chain of dispensaries across multiple states. Their strategic acquisitions and mergers have only expanded their footprint, allowing them to tap into diverse markets with varying regulatory landscapes. By establishing a strong retail presence, Curaleaf deftly navigates the complex regulatory frameworks governing cannabis sales, enhancing their market reach and consumer base. Additionally, the company has been proactive in pursuing partnerships and brand extensions, further diversifying its offerings and appealing to a broader audience. This multi-faceted strategy enables Curaleaf to capture a significant share of the growing demand for cannabis-related products, setting a robust foundation for sustained financial growth in an industry poised for expansion.

CURA Intrinsic Value
3.7 CAD
Overvaluation 44%
Intrinsic Value
Price
C

See Also

What is Curaleaf Holdings Inc's Total Receivables?
Total Receivables
43.8m USD

Based on the financial report for Sep 30, 2023, Curaleaf Holdings Inc's Total Receivables amounts to 43.8m USD.

What is Curaleaf Holdings Inc's Total Receivables growth rate?
Total Receivables CAGR 3Y
24%

Over the last year, the Total Receivables growth was -30%. The average annual Total Receivables growth rates for Curaleaf Holdings Inc have been 24% over the past three years .

Back to Top